JB Chemicals & Pharmaceuticals has informed that Company's API manufacturing facility at Panoli, Gujarat has successfully passed periodical inspection by US FDA with two minor procedural observations. These observations do not impact continuity of Company's business and the Company would continue its manufacturing activities in CGMP compliant manner. The Company proposes to address these observations in next 30 days. The said inspection was carried out from 7-5-2018 to 11-5-2018. This US FDA/EU/Japan approved API facility primarily manufactures APIs for exports to EU and formulations exports to US.
The above information is a part of company’s filings submitted to BSE.
